We are live on ! Find out more
FBT icon

First Trust NYSE Arca Biotechnology Index Fund
FBT

236 hedge funds and large institutions have $860M invested in First Trust NYSE Arca Biotechnology Index Fund in 2021 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 70 increasing their positions, 79 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

27% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 22

1% more funds holding

Funds holding: 233 → 236 (+3)

1.02% more ownership

Funds ownership: 46.07% → 47.09% (+1%)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

5% less capital invested

Capital invested by funds: $908M → $860M (-$47.4M)

11% less repeat investments, than reductions

Existing positions increased: 70 | Existing positions reduced: 79

Holders
236
Holders Change
+3
Holders Change %
+1.29%
% of All Funds
4.13%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
28
Increased
70
Reduced
79
Closed
22
Calls
$1.81M
Puts
–
Net Calls
+$1.81M
Net Calls Change
+$999K

Top Buyers

Rank Fund Capital Flow
1
KCM
Karp Capital Management
California
+$11.1M
2
AIC
Ameritas Investment Company
Nebraska
+$6.63M
3
QAM
Q3 Asset Management
Michigan
+$5.96M
4
AA
Ancora Advisors
Ohio
+$3.61M
5
HI
Harbour Investments
Wisconsin
+$3.15M

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$19.2M
2
Wells Fargo
Wells Fargo
California
-$7.19M
3
Envestnet Asset Management
Envestnet Asset Management
Illinois
-$5.16M
4
LPL Financial
LPL Financial
California
-$4.41M
5
RJA
Raymond James & Associates
Florida
-$3.31M
Name Holding Trade Value Shares
Change 		Change in
Stake
SFPG
126
Stonebridge Financial Planning Group
Florida
$358K -$87.1K -510 -20%
JCM
127
Jacobi Capital Management
Pennsylvania
$357K – – –
MML Investors Services
128
MML Investors Services
Massachusetts
$352K -$28.7K -168 -7%
SFP
129
Shepherd Financial Partners
Massachusetts
$344K – – –
NFG
130
Next Financial Group
Texas
$341K -$87.5K -512 -20%
LFF
131
Level Four Financial
Texas
$341K +$39.6K +232 +13%
CAL
132
Capital Analysts LLC
Pennsylvania
$334K – – –
GWSG
133
GPS Wealth Strategies Group
Colorado
$331K +$10.2K +60 +3%
EH
134
Equitable Holdings
New York
$313K +$86.6K +507 +37%
CF
135
Centaurus Financial
California
$304K -$351K -2,054 -53%
CWA
136
Clarus Wealth Advisors
Arizona
$296K -$854 -5 -0.3%
KA
137
Kovack Advisors
Florida
$296K +$8.54K +50 +3%
HIA
138
Harbor Investment Advisory
Maryland
$285K – – –
BCM
139
Breiter Capital Management
Florida
$282K – – –
CWM
140
Campbell Wealth Management
Virginia
$281K – – –
SWM
141
Selective Wealth Management
Virginia
$273K +$188K +1,100 +201%
FEG
142
Financial Enhancement Group
Indiana
$271K +$29.4K +172 +12%
AWA
143
Arkadios Wealth Advisors
Georgia
$265K +$25.5K +149 +10%
IFG
144
Independent Financial Group
California
$258K +$8.03K +47 +3%
GSWM
145
Golden State Wealth Management
California
$251K – – –
Northern Trust
146
Northern Trust
Illinois
$249K +$257K +1,502 New
ST
147
Spinnaker Trust
Maine
$236K – – –
FIM
148
Freedom Investment Management
Connecticut
$233K -$6.15K -36 -3%
GWM
149
Geneos Wealth Management
Colorado
$231K -$12.8K -75 -5%
WS
150
Wedbush Securities
California
$230K -$21.7K -127 -8%
4 5
6
7 8

FBT Hedge Fund Activity: Q3 2021 in Review

236 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in First Trust NYSE Arca Biotechnology Index Fund (FBT) for Q3 2021, worth a combined $860M — down 5.2% from $908M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new FBT positions and 22 closed out — a net gain of 6 holders — while 70 added to existing stakes and 79 trimmed.

The largest buyer was Karp Capital Management, opening a new position worth an estimated $11.1M. The largest seller was Morgan Stanley, cutting an estimated $19.2M.

  • 236 institutional investors held First Trust NYSE Arca Biotechnology Index Fund (FBT) as of Q3 2021, up from 233 in Q2 2021.
  • Funds reported $860M of First Trust NYSE Arca Biotechnology Index Fund stock for Q3 2021, down 5.2% quarter-over-quarter.
  • 28 funds opened new First Trust NYSE Arca Biotechnology Index Fund positions in Q3 2021 and 22 closed out, a net change of +6 holders.
  • The largest First Trust NYSE Arca Biotechnology Index Fund buyer in Q3 2021 was Karp Capital Management, an estimated $11.1M added.
  • The largest First Trust NYSE Arca Biotechnology Index Fund seller in Q3 2021 was Morgan Stanley, an estimated $19.2M sold.

Based on aggregated 13F filings for Q3 2021.